Skip to main content
Top
Published in: Endocrine 3/2014

01-08-2014 | Original Article

Prediction of gestational diabetes mellitus in the first trimester, comparison of fasting plasma glucose, two-step and one-step methods: a prospective randomized controlled trial

Authors: M. Ilkin Yeral, A. Seval Ozgu-Erdinc, Dilek Uygur, K. Doga Seckin, M. Fatih Karsli, A. Nuri Danisman

Published in: Endocrine | Issue 3/2014

Login to get access

Abstract

Our aim was to evaluate and compare the diagnostic performance of three methods commonly used for GDM screening: fasting plasma glucose (FPG), two-step 50 g glucose challenge test (GCT), and 75 g glucose tolerance test (GTT) in a randomized study design to predict GDM in the first trimester and determine the best approach in predicting GDM. In a non-blind, parallel-group prospective randomized controlled study; 736 singleton pregnant women underwent FPG testing in the first trimester and randomly assigned to two groups; two-step 50 g GCT and 75 g GTT. GDM diagnosis was made according to Carpenter–Coustan or ADA (American Diabetes Association) criteria in two-step 50 g GCT and 75 g GTT groups, respectively. Subsequent testing was performed by two-step 50 g GCT at 24–28 weeks for screen negatives. After excluding the women who were lost to follow-up or withdrawn as a result of pregnancy loss, 486 pregnant women were recruited in the study. The FPG, two-step GCT, and one-step GTT methods identified GDM in 25/486 (5.1 %), 15/248 (6.0 %), and 27/238 (11.3 %) women, respectively. Area under ROC curves were 0.623, 0.708, and 0.792, respectively. Sensitivities were 47.17, 68.18, and 87.1 %, respectively. Specificities were 77.37, 100, and 100 %, respectively. Positive predictive values were 20.33, 100, and 100 %, respectively. Negative predictive values were 92.29, 97, and 98.1 %, respectively. Until superior screening alternatives become available, the 75 g GTT may be preferred for GDM screening in the first trimester.
Literature
3.
4.
go back to reference Canadian Diabetes Association, Clinical practice guidelines for the prevention and management of diabetes in Canada. Can. J. Diabetes 32(suppl 1), 1–201 (2008) Canadian Diabetes Association, Clinical practice guidelines for the prevention and management of diabetes in Canada. Can. J. Diabetes 32(suppl 1), 1–201 (2008)
6.
go back to reference B.E. Metzger, S.G. Gabbe, B. Persson, T.A. Buchanan, P.A. Catalano, P. Damm, A.R. Dyer, A. Leiva, M. Hod, J.L. Kitzmiler, L.P. Lowe, H.D. McIntyre, J.J. Oats, Y. Omori, M.I. Schmidt, International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 33(3), 676–682 (2010)PubMedCrossRef B.E. Metzger, S.G. Gabbe, B. Persson, T.A. Buchanan, P.A. Catalano, P. Damm, A.R. Dyer, A. Leiva, M. Hod, J.L. Kitzmiler, L.P. Lowe, H.D. McIntyre, J.J. Oats, Y. Omori, M.I. Schmidt, International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 33(3), 676–682 (2010)PubMedCrossRef
9.
go back to reference ACOG, Practice bulletin gestational diabetes. Number 30, September 2001. Obstet. Gynecol. 98(3), 525–538 (2001) ACOG, Practice bulletin gestational diabetes. Number 30, September 2001. Obstet. Gynecol. 98(3), 525–538 (2001)
11.
go back to reference J. Tieu, P. Middleton, A.J. McPhee, C.A. Crowther, Screening and subsequent management for gestational diabetes for improving maternal and infant health. Cochrane. Database Syst. Rev. 7, CD007222 (2010). doi:10.1002/14651858.CD007222.pub2 J. Tieu, P. Middleton, A.J. McPhee, C.A. Crowther, Screening and subsequent management for gestational diabetes for improving maternal and infant health. Cochrane. Database Syst. Rev. 7, CD007222 (2010). doi:10.​1002/​14651858.​CD007222.​pub2
12.
go back to reference D.R. Coustan, Point: the American Diabetes Association and the International Association of Diabetes and Pregnancy study groups recommendations for diagnosing gestational diabetes should be used worldwide. Clin. Chem. 58(7), 1094–1097 (2012). doi:10.1373/clinchem.2012.186239 PubMedCrossRef D.R. Coustan, Point: the American Diabetes Association and the International Association of Diabetes and Pregnancy study groups recommendations for diagnosing gestational diabetes should be used worldwide. Clin. Chem. 58(7), 1094–1097 (2012). doi:10.​1373/​clinchem.​2012.​186239 PubMedCrossRef
14.
go back to reference W. Plasencia, R. Garcia, S. Pereira, R. Akolekar, K.H. Nicolaides, Criteria for screening and diagnosis of gestational diabetes mellitus in the first trimester of pregnancy. Fetal Diagn. Ther. 30(2), 108–115 (2011). doi:10.1159/000324684 PubMedCrossRef W. Plasencia, R. Garcia, S. Pereira, R. Akolekar, K.H. Nicolaides, Criteria for screening and diagnosis of gestational diabetes mellitus in the first trimester of pregnancy. Fetal Diagn. Ther. 30(2), 108–115 (2011). doi:10.​1159/​000324684 PubMedCrossRef
15.
go back to reference D.A. Sacks, W. Chen, G. Wolde-Tsadik, T.A. Buchanan, Fasting plasma glucose test at the first prenatal visit as a screen for gestational diabetes. Obstet. Gynecol. 101(6), 1197–1203 (2003)PubMedCrossRef D.A. Sacks, W. Chen, G. Wolde-Tsadik, T.A. Buchanan, Fasting plasma glucose test at the first prenatal visit as a screen for gestational diabetes. Obstet. Gynecol. 101(6), 1197–1203 (2003)PubMedCrossRef
19.
go back to reference M.W. Carpenter, D.R. Coustan, Criteria for screening tests for gestational diabetes. Am. J. Obstet. Gynecol. 144(7), 768–773 (1982)PubMed M.W. Carpenter, D.R. Coustan, Criteria for screening tests for gestational diabetes. Am. J. Obstet. Gynecol. 144(7), 768–773 (1982)PubMed
20.
go back to reference J.P. Vandorsten, W.C. Dodson, M.A. Espeland, W.A. Grobman, J.M. Guise, B.M. Mercer, H.L. Minkoff, B. Poindexter, L.A. Prosser, G.F. Sawaya, J.R. Scott, R.M. Silver, L. Smith, A. Thomas, A.T. Tita, NIH consensus development conference: diagnosing Gestational diabetes mellitus. NIH consens state Sci Statements 29(1), 1–31 (2013)PubMed J.P. Vandorsten, W.C. Dodson, M.A. Espeland, W.A. Grobman, J.M. Guise, B.M. Mercer, H.L. Minkoff, B. Poindexter, L.A. Prosser, G.F. Sawaya, J.R. Scott, R.M. Silver, L. Smith, A. Thomas, A.T. Tita, NIH consensus development conference: diagnosing Gestational diabetes mellitus. NIH consens state Sci Statements 29(1), 1–31 (2013)PubMed
21.
go back to reference C. Erem, N. Cihanyurdu, O. Deger, C. Karahan, G. Can, M. Telatar, Screening for gestational diabetes mellitus in northeastern Turkey (Trabzon City). Eur. J. Epidemiol. 18(1), 39–43 (2003)PubMedCrossRef C. Erem, N. Cihanyurdu, O. Deger, C. Karahan, G. Can, M. Telatar, Screening for gestational diabetes mellitus in northeastern Turkey (Trabzon City). Eur. J. Epidemiol. 18(1), 39–43 (2003)PubMedCrossRef
22.
go back to reference D. Karcaaltincaba, O. Kandemir, S. Yalvac, S. Guvendag-Guven, A. Haberal, Prevalence of gestational diabetes mellitus and gestational impaired glucose tolerance in pregnant women evaluated by National Diabetes Data Group and Carpenter and Coustan criteria. Int. J. Gynaecol. Obstet. 106(3), 246–249 (2009). doi:10.1016/j.ijgo.2009.04.004 PubMedCrossRef D. Karcaaltincaba, O. Kandemir, S. Yalvac, S. Guvendag-Guven, A. Haberal, Prevalence of gestational diabetes mellitus and gestational impaired glucose tolerance in pregnant women evaluated by National Diabetes Data Group and Carpenter and Coustan criteria. Int. J. Gynaecol. Obstet. 106(3), 246–249 (2009). doi:10.​1016/​j.​ijgo.​2009.​04.​004 PubMedCrossRef
23.
go back to reference F. Faul, E. Erdfelder, A.G. Lang, A. Buchner, G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav. Res. Methods 39(2), 175–191 (2007)PubMedCrossRef F. Faul, E. Erdfelder, A.G. Lang, A. Buchner, G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav. Res. Methods 39(2), 175–191 (2007)PubMedCrossRef
24.
go back to reference G.G. Nahum, B.J. Huffaker, Correlation between first- and early third-trimester glucose screening test results. Obstet. Gynecol. 76(4), 709–713 (1990)PubMed G.G. Nahum, B.J. Huffaker, Correlation between first- and early third-trimester glucose screening test results. Obstet. Gynecol. 76(4), 709–713 (1990)PubMed
25.
go back to reference S.M. Bhattacharya, Glucose screening test results in first and early third trimester of pregnancy: is there any correlation? J. Obstet. Gynaecol. Res. 28(6), 304–307 (2002)PubMedCrossRef S.M. Bhattacharya, Glucose screening test results in first and early third trimester of pregnancy: is there any correlation? J. Obstet. Gynaecol. Res. 28(6), 304–307 (2002)PubMedCrossRef
27.
go back to reference D.A. Scott, E. Loveman, L. McIntyre, N. Waugh, Screening for gestational diabetes: a systematic review and economic evaluation. Health Technol. Assess. 6(11), 1–161 (2002)PubMed D.A. Scott, E. Loveman, L. McIntyre, N. Waugh, Screening for gestational diabetes: a systematic review and economic evaluation. Health Technol. Assess. 6(11), 1–161 (2002)PubMed
28.
29.
go back to reference T. Bito, T. Nyari, L. Kovacs, A. Pal, Oral glucose tolerance testing at gestational weeks ≤16 could predict or exclude subsequent gestational diabetes mellitus during the current pregnancy in high risk group. Eur. J. Obstet. Gynecol. Reprod. Biol. 121(1), 51–55 (2005). doi:10.1016/j.ejogrb.2004.11.006 PubMedCrossRef T. Bito, T. Nyari, L. Kovacs, A. Pal, Oral glucose tolerance testing at gestational weeks ≤16 could predict or exclude subsequent gestational diabetes mellitus during the current pregnancy in high risk group. Eur. J. Obstet. Gynecol. Reprod. Biol. 121(1), 51–55 (2005). doi:10.​1016/​j.​ejogrb.​2004.​11.​006 PubMedCrossRef
30.
go back to reference D.M. Jensen, L. Molsted-Pedersen, H. Beck-Nielsen, J.G. Westergaard, P. Ovesen, P. Damm, Screening for gestational diabetes mellitus by a model based on risk indicators: a prospective study. Am. J. Obstet. Gynecol. 189(5), 1383–1388 (2003)PubMedCrossRef D.M. Jensen, L. Molsted-Pedersen, H. Beck-Nielsen, J.G. Westergaard, P. Ovesen, P. Damm, Screening for gestational diabetes mellitus by a model based on risk indicators: a prospective study. Am. J. Obstet. Gynecol. 189(5), 1383–1388 (2003)PubMedCrossRef
31.
go back to reference D.R. Danilenko-Dixon, J.T. Van Winter, R.L. Nelson, P.L. Ogburn Jr, Universal versus selective gestational diabetes screening: application of 1997 American Diabetes Association recommendations. Am. J. Obstet. Gynecol. 181(4), 798–802 (1999)PubMedCrossRef D.R. Danilenko-Dixon, J.T. Van Winter, R.L. Nelson, P.L. Ogburn Jr, Universal versus selective gestational diabetes screening: application of 1997 American Diabetes Association recommendations. Am. J. Obstet. Gynecol. 181(4), 798–802 (1999)PubMedCrossRef
32.
go back to reference I. Satman, T. Yilmaz, A. Sengul, S. Salman, F. Salman, S. Uygur, I. Bastar, Y. Tutuncu, M. Sargin, N. Dinccag, K. Karsidag, S. Kalaca, C. Ozcan, H. King, Population-based study of diabetes and risk characteristics in Turkey: results of the Turkish diabetes epidemiology study (TURDEP). Diabetes Care 25(9), 1551–1556 (2002)PubMedCrossRef I. Satman, T. Yilmaz, A. Sengul, S. Salman, F. Salman, S. Uygur, I. Bastar, Y. Tutuncu, M. Sargin, N. Dinccag, K. Karsidag, S. Kalaca, C. Ozcan, H. King, Population-based study of diabetes and risk characteristics in Turkey: results of the Turkish diabetes epidemiology study (TURDEP). Diabetes Care 25(9), 1551–1556 (2002)PubMedCrossRef
33.
go back to reference I. Satman, B. Omer, Y. Tutuncu, S. Kalaca, S. Gedik, N. Dinccag, K. Karsidag, S. Genc, A. Telci, B. Canbaz, F. Turker, T. Yilmaz, B. Cakir, J. Tuomilehto, T.-I.S. Group, Twelve-year trends in the prevalence and risk factors of diabetes and prediabetes in Turkish adults. Eur. J. Epidemiol. 28(2), 169–180 (2013). doi:10.1007/s10654-013-9771-5 PubMedCentralPubMedCrossRef I. Satman, B. Omer, Y. Tutuncu, S. Kalaca, S. Gedik, N. Dinccag, K. Karsidag, S. Genc, A. Telci, B. Canbaz, F. Turker, T. Yilmaz, B. Cakir, J. Tuomilehto, T.-I.S. Group, Twelve-year trends in the prevalence and risk factors of diabetes and prediabetes in Turkish adults. Eur. J. Epidemiol. 28(2), 169–180 (2013). doi:10.​1007/​s10654-013-9771-5 PubMedCentralPubMedCrossRef
34.
go back to reference T. Siegmund, N.T. Rad, C. Ritterath, G. Siebert, W. Henrich, K.J. Buhling, Longitudinal changes in the continuous glucose profile measured by the CGMS in healthy pregnant women and determination of cut-off values. Eur. J. Obstet. Gynecol. Reprod. Biol. 139(1), 46–52 (2008). doi:10.1016/j.ejogrb.2007.12.006 PubMedCrossRef T. Siegmund, N.T. Rad, C. Ritterath, G. Siebert, W. Henrich, K.J. Buhling, Longitudinal changes in the continuous glucose profile measured by the CGMS in healthy pregnant women and determination of cut-off values. Eur. J. Obstet. Gynecol. Reprod. Biol. 139(1), 46–52 (2008). doi:10.​1016/​j.​ejogrb.​2007.​12.​006 PubMedCrossRef
36.
go back to reference W.W. Zhu, H.X. Yang, Y.M. Wei, J. Yan, Z.L. Wang, X.L. Li, H.R. Wu, N. Li, M.H. Zhang, X.H. Liu, H. Zhang, Y.H. Wang, J.M. Niu, Y.J. Gan, L.R. Zhong, Y.F. Wang, A. Kapur, Evaluation of the value of fasting plasma glucose in the first prenatal visit to diagnose gestational diabetes mellitus in china. Diabetes Care 36(3), 586–590 (2013). doi:10.2337/dc12-1157 PubMedCentralPubMedCrossRef W.W. Zhu, H.X. Yang, Y.M. Wei, J. Yan, Z.L. Wang, X.L. Li, H.R. Wu, N. Li, M.H. Zhang, X.H. Liu, H. Zhang, Y.H. Wang, J.M. Niu, Y.J. Gan, L.R. Zhong, Y.F. Wang, A. Kapur, Evaluation of the value of fasting plasma glucose in the first prenatal visit to diagnose gestational diabetes mellitus in china. Diabetes Care 36(3), 586–590 (2013). doi:10.​2337/​dc12-1157 PubMedCentralPubMedCrossRef
37.
go back to reference A. Lapolla, M.G. Dalfra, E. Ragazzi, A.P. De Cata, D. Fedele, New International Association of the Diabetes and Pregnancy Study Groups (IADPSG) recommendations for diagnosing gestational diabetes compared with former criteria: a retrospective study on pregnancy outcome. Diabet. Med. 28(9), 1074–1077 (2011). doi:10.1111/j.1464-5491.2011.03351.x PubMedCrossRef A. Lapolla, M.G. Dalfra, E. Ragazzi, A.P. De Cata, D. Fedele, New International Association of the Diabetes and Pregnancy Study Groups (IADPSG) recommendations for diagnosing gestational diabetes compared with former criteria: a retrospective study on pregnancy outcome. Diabet. Med. 28(9), 1074–1077 (2011). doi:10.​1111/​j.​1464-5491.​2011.​03351.​x PubMedCrossRef
Metadata
Title
Prediction of gestational diabetes mellitus in the first trimester, comparison of fasting plasma glucose, two-step and one-step methods: a prospective randomized controlled trial
Authors
M. Ilkin Yeral
A. Seval Ozgu-Erdinc
Dilek Uygur
K. Doga Seckin
M. Fatih Karsli
A. Nuri Danisman
Publication date
01-08-2014
Publisher
Springer US
Published in
Endocrine / Issue 3/2014
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-013-0111-z

Other articles of this Issue 3/2014

Endocrine 3/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.